Synlogic
Steven Kates has a strong background in regulatory affairs, spanning several companies over the years. Starting in 2016, they held the role of CSO and VP of Regulatory Affairs at Lakewood Amedex until 2019. From there, they moved on to Dicerna Pharmaceuticals, Inc., where they served as the VP of Regulatory Affairs for three years. Most recently, in 2022, Steven joined Synlogic Operating Company, Inc. as the Vice President of Regulatory Affairs.
Steven Kates attended Brandeis University and Bates College, but no information is provided regarding the years they attended or the degrees they earned.
This person is not in any teams
Synlogic
1 followers
Synlogic is pioneering the development of a novel class of living Synthetic Biotic medicines based on its proprietary drug discovery and development platform.